Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RSJ Investments SICAV is a prominent Czech investment group that manages a broad range of private equity and venture capital funds. Through its specialized sub-fund, RSJ Gradus, the firm focuses significantly on the life sciences, biotechnology, and healthcare sectors. The group provides capital to companies developing innovative medical devices, diagnostics, and therapeutic solutions, particularly those in the later stages of development. RSJ's investment strategy emphasizes long-term value creation in high-tech industries and sustainable projects.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RSJ Investments SICAV.